Individual compoundsCategoriesResearch SetsMembershipJournalSign in
← Journal

The Hypothesis

Research Methodology

The Evidence Ladder: How to Read Peptide Research

2–25 min read

Not all scientific evidence answers the same question. A biochemical experiment can establish that a molecule interacts with a receptor. A cell-culture experiment can reveal changes in signalling. An animal model can demonstrate a physiological response. An uncontrolled human study can identify an interesting association. A randomized controlled trial can test whether an intervention produces a measurable effect under defined conditions. None of these, individually, proves everything about a molecule.

This distinction becomes particularly important in peptide research because different compounds occupy dramatically different positions on the evidence ladder.

Retatrutide, for example, has been investigated in large randomized human trials. Tesamorelin has similarly been investigated through randomized human clinical research in a defined population. BPC-157 is very different: a 2025 systematic assessment of its orthopaedic and sports-medicine literature found that 35 of 36 eligible studies were preclinical. KPV occupies another position, with its mechanistic literature arising almost entirely from cellular and murine models.

These differences do not make early-stage research worthless. Quite the opposite -- cellular and animal research is how many important biological discoveries begin. The mistake is not studying preliminary evidence. The mistake is presenting preliminary evidence as though later stages of validation have already occurred.

NORTEAVA therefore uses the following evidence hierarchy when discussing research: mechanism, then cellular evidence, then animal or preclinical evidence, then human observational evidence, then controlled human trials, then replication and longer-term evidence. The further a claim progresses through that sequence, the greater the confidence that can reasonably be placed in it.

Where evidence remains preliminary, we say so. Where human trials exist, we distinguish their population, endpoints and limitations. Where findings conflict, we present the disagreement. And where research has not yet answered a question, uncertainty is the scientifically correct answer.

Research Status

This entry describes NORTEAVA's own editorial methodology, illustrated with real examples spanning the evidence ladder -- it is a standard we apply, not a study result.

Selected Research

Related Research